Atractylone in the Atractylodes macrocephala Rhizoma Essential Oil and Its Anti-Inflammatory Activity
Open Access
Abstract
The aim of this study was to conduct a screening of potential therapeutic compounds found in the Atractylodes macrocephala rhizoma essential oil (AO) and explore its mechanism of action in the treatment of ulcerative colitis (UC). An inflammation cell model was employed in conjunction with phospho-antibody array technology to explore potential therapeutic compounds of AO and their anti-inflammatory and antioxidant effects. Furthermore, we assessed their efficacy and mechanisms of action in treating dextran sulfate sodium (DSS)-induced colitis in mice. Via the screening process, we identified atractylone (ATR) as the primary active compound in AO. It has been demonstrated that ATR can both decrease the levels of tumor necrosis factor (TNF)-α and reactive oxygen species (ROS) and increase the expression of adhesion proteins such as claudin, ZO-1, and occludin in vitro. Moreover, ATR has been shown to improve UC symptoms in vivo. Via a non-targeted metabolomics analysis of colon tissue, we identified 57 distinct metabolites that responded to ATR treatment. Subsequent analysis of the metabolic pathways revealed that the action of ATR was primarily focused on the amino acid metabolism pathway. In summary, ATR may alleviate the symptoms of UC by regulating multiple signaling pathways. Additionally, ATR has a comprehensive function in anti-inflammation, antioxidative stress, and intestinal injury reduction.Keywords
Funding Information
- The Program of Shanghai Leading Talents (SHLJ2019100, 23KFL046, 2022YFC3501705, 82274066)
- the Science and Technology Development Fund of Shanghai University of Traditional Chinese Medicine (SHLJ2019100, 23KFL046, 2022YFC3501705, 82274066)
- the national key Research and Development Program of China (SHLJ2019100, 23KFL046, 2022YFC3501705, 82274066)
- he National Natural Science Foundation of China general projects (SHLJ2019100, 23KFL046, 2022YFC3501705, 82274066)
This publication has 40 references indexed in Scilit:
- Cytokines in inflammatory bowel diseaseNature Reviews Immunology, 2014
- Glutamate microinjection into the hypothalamic paraventricular nucleus attenuates ulcerative colitis in ratsActa Pharmacologica Sinica, 2013
- Review article: remission rates achievable by current therapies for inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2011
- Oxidative DNA Damage and Antioxidant Activity in Patients with Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2007
- Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compoundsCarcinogenesis, 2006
- Regulatory mechanisms and functions of MAP kinase signaling pathwaysIUBMB Life, 2006
- Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease 1,2 1This article is part of a series of reviews on “Reactive Oxygen and Nitrogen in Inflammation.” The full list of papers may be found on the homepage of the journal. 2Guest Editor: Giuseppe PoliFree Radical Biology and Medicine, 2002
- p38 Mitogen-Activated Protein Kinase Is Activated and Linked to TNF-α Signaling in Inflammatory Bowel DiseaseThe Journal of Immunology, 2002
- Neutrophil Transmigration in Inflammatory Bowel Disease Is Associated with Differential Expression of Epithelial Intercellular Junction ProteinsThe American Journal of Pathology, 2001
- Studies on the Constituents of Atractylodes. IX. Structure and Autoxidation of AtractylonChemical and Pharmaceutical Bulletin, 1964